Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/CRL
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Charles River Laboratories Intl. Inc (CRL) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Charles River Laboratories (CRL) trades at $291.93, up 2.39% today, with strong analyst support (73% buy ratings) despite negative profitability metrics. The stock shows bullish technical momentum with recent earnings beats and positive cash flow trends. Recent developments include new automated manufacturing capabilities and vaccine development collaborations, supporting growth prospects.
The outlook remains cautiously optimistic given consistent earnings outperformance and operational improvements, though elevated valuation ratios and negative net income margins present significant risks. Investors should weigh strong institutional sentiment against fundamental challenges in the competitive healthcare services sector.
Read full analysis

Key Stats

  • Market Cap
    $13.24B
  • Volume
    1,594,218
  • Sector
    Health
  • 52W High
    $298.58
  • 52W Low
    $145.57
  • Typical Hold Time
    34 Days
  • Enterprise Value
    $16.08B
  • Div Yield
    -
  • Trading Activity
    -
$294.02
52W Low: $145.57
25 Sep 2025
52W High: $298.58
24 Aug 2026

Track Charles River Laboratories Intl. Inc (CRL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $145.57 and a high of $298.58, highlighting its annual price range. Buy and sell Charles River Laboratories Intl. Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Most Recent News

Content is generated by Aura AI

General Mills sees 3% sales drop but beats earnings estimates with strong international growth.

General Mills reported a 3% decline in sales to $4.40 billion, partly due to selling its U.S. yogurt business, causing adjusted gross margin to fall to 33.3%. Despite this, the company beat earnings expectations with adjusted EPS of $0.75, helped by ...

Market News
3 hours ago
Alex Lavoie
Neutral
General Mills sees 3% sales drop but beats earnings estimates with strong international growth.

Mastercard forecasts 5.5% holiday retail sales growth, half driven by inflation, boosting its fee revenue potential.

Mastercard's chief economist projects a 5.5% growth in U.S. retail sales for the holiday season, but notes that about half of this growth is due to inflation rather than increased transaction volume. This inflation-driven growth benefits Mastercard d...

Market News
4 hours ago
24/7 Wall Street
Neutral
Mastercard forecasts 5.5% holiday retail sales growth, half driven by inflation, boosting its fee revenue potential.

Gold dips as U.S. new home sales beat expectations with 6.4% rise in August

U.S. new home sales surged 6.4% in August, doubling forecasts and signaling strength in the housing market despite recent Fed rate hikes. Sales hit an annualized rate of 684,000 units, above the expected 620,000, with July sales also revised higher. ...

Market News
4 hours ago
Kitco
Neutral
Gold dips as U.S. new home sales beat expectations with 6.4% rise in August
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $13.24B
  • Volume
    1,594,218
  • Sector
    Health
  • 52W High
    $298.58
  • 52W Low
    $145.57
  • Typical Hold Time
    34 Days
  • Enterprise Value
    $16.08B
  • Div Yield
    -
  • Trading Activity
    -
$294.02
52W Low: $145.57
25 Sep 2025
52W High: $298.58
24 Aug 2026

Track Charles River Laboratories Intl. Inc (CRL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Charles River Laboratories Intl. Inc has traded between a low of $145.57 and a high of $298.58, highlighting its annual price range. Buy and sell Charles River Laboratories Intl. Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!